Albion Financial Group Evolus, Inc. Transaction History

Albion Financial Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$8.42 - $13.96 $79,122 - $131,182	-9,397 Closed	0 $0
Q4 2020 Feb 19, 2021	BUY	$2.92 - $4.84 $27,439 - $45,481	9,397 New	9,397 $32,000
Q2 2019 Aug 08, 2019	SELL	$13.19 - $28.36 $123,946 - $266,498	-9,397 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$12.43 - $28.91 $116,804 - $271,667	9,397 New	9,397 $212,000

186

55.2M

1.21M

48.5K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $377M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.